Overview
STVN market data
Price History
STVN price chart · 1M
- O
- 22.35
- H
- 22.38
- L
- 22.13
- C
- 22.13
- Vol
- 20,592.00
- Source
- US equities market feed
- Observed
- Aug 27, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $22.35
- Previous Close
- $22.42
- Day High
- $22.38
- Day Low
- $22.13
- 52 Week High
- $23.17
- 52 Week Low
- $16.05
- 7 Day Return
- -0.87%
- 30 Day Return
- +9.50%
- 90 Day Return
- +19.30%
- 1 Year Return
- +36.44%
- Daily Notional Volume
- $455.7K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 37.83 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $0.51 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.76 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 0.2% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 11.0% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $12.89 – $28.00 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $5.9B · P/B 3.20 · P/S 4.16.
Company News
Stevanato Group Q2 2026 Earnings Call: Complete TranscriptBenzinga · Aug 4, 2026, 1:36 PM
Stevanato Group Lowers FY2026 GAAP EPS Guidance from $0.64-$0.69 to $0.62-$0.64; Lowers FY2026 Sales Guidance from $1.467B-$1.500B to $1.465B-$1.488BBenzinga · Aug 4, 2026, 10:43 AM
Stevanato Group Narrows FY2026 Adj EPS Guidance from $0.69-$0.73 to $0.70-$0.72 vs $0.68 Est; Lowers FY2026 Sales Guidance from $1.467B-$1.500B to $1.465B-$1.488B vs $1.500B EstBenzinga · Aug 4, 2026, 10:40 AM
Stevanato Gr Q2 Adj. EPS $0.16 Beats $0.14 Estimate, Sales $351.091M Miss $351.370M EstimateBenzinga · Aug 4, 2026, 10:30 AM
Stevanato Group Says Liraglutide-Based Combination Products Incorporating Its Proprietary Alina Pen Injector Platform Receives Marketing Authorizations In EuropeBenzinga · Jul 30, 2026, 10:37 AM
TD Cowen Initiates Coverage On Stevanato Group with Buy Rating, Announces Price Target of $25Benzinga · Jun 16, 2026, 5:10 PM
Merlin, Concrete Pumping Holdings, And Krispy Kreme And Other Big Stocks Moving Higher On FridayBenzinga · Jun 5, 2026, 2:40 PM
Wolfe Research Assumes Stevanato Group at Outperform, Announces Price Target of $21Benzinga · Jun 2, 2026, 11:30 AM